EUVIMEDEUVIMED entdecken
Crossref

Exploring Hematoma Expansion Shift With Recombinant Factor VIIa: A Pooled Analysis of 4 Randomized Controlled Trials

Vignan Yogendrakumar iD, Stephan A Mayer iD, Thorsten Steiner, Joseph P Broderick iD, Dar Dowlatshahi iD

Stroke · 2023

DOI: 10.1161/strokeaha.123.043209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2023. Verfasst von Vignan Yogendrakumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia (V.Y.). Hauptthemen laut MEDLINE: Factor VIIa, Cerebral Hemorrhage. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hematoma expansion shift (HES) analysis can be used to assess the biological effect of a hemostatic therapy for intracerebral hemorrhage. In this study, we applied HES analysis to individual patient data from 4 randomized controlled trials evaluating rFVIIa (recombinant factor VIIa) 80 μg/kg to placebo. METHODS: We generated polychotomous strata of HES using absolute growth thresholds (≤0/

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor VIIaCerebral HemorrhageHumansRandomized Controlled Trials as TopicRecombinant ProteinsHematoma

Stichwörter der Autor:innen

cerebral hemorrhageclinical trialhematomahemostaticspatients

Substanzen

recombinant FVIIaFactor VIIaRecombinant Proteins

Autor:innen und Institutionen

  • Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia (V.Y.).
  • Departments of Neurology and Neurosurgery, New York Medical College, Valhalla, NY (S.A.M.).
  • Department of Neurology, Klinikum Frankfurt Höchst, Germany (T.H.).
  • Department of Neurology, Heidelberg University Hospital, Germany (T.H.).
  • University of Cincinnati Gardner Neuroscience Institute, OH (J.P.B.).
  • Department of Medicine (Neurology), University of Ottawa and Ottawa Hospital Research Institute, Ontario, Canada (D.D.).

ORCID-Profile: Vignan Yogendrakumar, Stephan A Mayer, Joseph P Broderick, Dar Dowlatshahi

Zitieren

APA

Yogendrakumar, V., Mayer, S. A., Steiner, T., Broderick, J. P., & Dowlatshahi, D. (2023). Exploring Hematoma Expansion Shift With Recombinant Factor VIIa: A Pooled Analysis of 4 Randomized Controlled Trials. Stroke. https://doi.org/10.1161/strokeaha.123.043209

Vancouver

Yogendrakumar V, Mayer SA, Steiner T, Broderick JP, Dowlatshahi D. Exploring Hematoma Expansion Shift With Recombinant Factor VIIa: A Pooled Analysis of 4 Randomized Controlled Trials. Stroke. 2023. doi:10.1161/strokeaha.123.043209

BibTeX
@article{Yogendrakumar2023,
  author = {Yogendrakumar, Vignan and Mayer, Stephan A and Steiner, Thorsten and Broderick, Joseph P and Dowlatshahi, Dar},
  title = {Exploring Hematoma Expansion Shift With Recombinant Factor VIIa: A Pooled Analysis of 4 Randomized Controlled Trials},
  journal = {Stroke},
  year = {2023},
  doi = {10.1161/strokeaha.123.043209}
}
Kostenlos starten →